However, clinical features of diabetic nephropathy, including albuminuria, urinary markers of tubule damage (KIM-1 and NGAL), kidney growth, and glomerulosclerosis were not improved in this study, even when empagliflozin was co-administered with metformin. This evidence concerns the gene HAVCR1 and glomerulosclerosis.